Somewhat Positive Media Coverage Somewhat Unlikely to Impact GNC (GNC) Stock Price

News stories about GNC (NYSE:GNC) have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. GNC earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the specialty retailer an impact score of 46.2116422890302 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Several brokerages have issued reports on GNC. Robert W. Baird reaffirmed a “hold” rating and set a $10.00 price objective on shares of GNC in a report on Sunday, September 17th. ValuEngine raised GNC from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Barclays dropped their price objective on GNC from $9.00 to $6.00 and set an “underweight” rating on the stock in a report on Friday, October 27th. Finally, Zacks Investment Research lowered GNC from a “hold” rating to a “strong sell” rating in a report on Friday, October 27th. Five investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $8.10.

GNC (GNC) traded up $0.18 during midday trading on Friday, hitting $3.57. The company had a trading volume of 3,174,507 shares, compared to its average volume of 4,406,558. The company has a debt-to-equity ratio of -55.95, a quick ratio of 0.70 and a current ratio of 2.44. GNC has a 52-week low of $3.13 and a 52-week high of $11.79. The stock has a market capitalization of $246.34, a price-to-earnings ratio of -0.65 and a beta of 0.79.

GNC (NYSE:GNC) last released its quarterly earnings results on Thursday, October 26th. The specialty retailer reported $0.32 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.33 by ($0.01). GNC had a negative return on equity of 133.37% and a negative net margin of 15.11%. The company had revenue of $609.47 million for the quarter, compared to analysts’ expectations of $614.08 million. During the same period in the prior year, the business earned $0.59 EPS. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. equities analysts forecast that GNC will post 1.28 EPS for the current year.

In related news, EVP Tim Mantel purchased 20,000 shares of the stock in a transaction that occurred on Friday, November 10th. The shares were purchased at an average price of $5.80 per share, with a total value of $116,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.85% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first published by Week Herald and is the property of of Week Herald. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://weekherald.com/2018/01/07/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-gnc-gnc-stock-price.html.

GNC Company Profile

GNC Holdings, Inc is a specialty retailer of health, wellness and performance products, which include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. The Company’s operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products.

Insider Buying and Selling by Quarter for GNC (NYSE:GNC)

Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply